A closed genome of Streptococcus agalactiae ST347/II reveals a composite integrative element coupling nisin P biosynthesis to erm(B) and tet(O) in Dominican group B Streptococcus
This study presents the first closed genome of a Dominican *Streptococcus agalactiae* ST347/II isolate, revealing a novel composite integrative element that physically links nisin P biosynthesis to clindamycin and tetracycline resistance genes (*erm(B)* and *tet(O)*), thereby establishing a tight genetic association between lantibiotic production and macrolide-lincosamide-streptogramin B resistance that is statistically supported but not physically linked in draft genomes.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
Every pregnant woman carries a tiny, invisible risk. In the lower intestine and vagina, a common bacterium called Group B Streptococcus often lives without causing any trouble. But if it passes to a newborn during birth, it can cause severe illness. To stop this, doctors give antibiotics to mothers who are colonized with the bacteria during labor. For most women, penicillin works perfectly. However, for those allergic to penicillin, doctors must use a different drug, clindamycin. The problem is that this backup drug is failing in some places because the bacteria have learned to resist it. Understanding exactly how and why this resistance spreads is a matter of life and death for newborns, yet scientists have been looking at the bacteria's genetic code through a blurry lens, unable to see the full picture of how these resistance genes travel together.
A team of researchers in the Dominican Republic has finally cleared that blur. They took a single sample of the bacteria from a diagnostic lab and sequenced its entire genetic code, creating a complete, unbroken circle of DNA rather than the fragmented pieces scientists usually work with. This complete view allowed them to see the physical arrangement of genes with perfect clarity. They discovered that the gene responsible for resisting clindamycin is not floating alone. Instead, it is physically stuck to a gene cluster that produces a natural antibiotic weapon called nisin P. This weapon is designed to kill competing bacteria, helping the Group B Streptococcus survive in the crowded environment of the human body. The researchers found that these two traits—the ability to make a weapon and the ability to ignore a medical drug—are linked on the same mobile genetic element, a stretch of DNA that can jump between bacteria.
The study focused on a specific strain of the bacteria, known as ST347, found in the Dominican Republic. By building a complete map of its genome, the team saw that the resistance gene for clindamycin sits just a tiny distance away from the genes that build the nisin P weapon. In fact, they are separated by only 96 base pairs, a gap so small that it is almost as if they are touching. This physical connection is crucial because it means the two traits are inherited together. When the bacteria passes this genetic element to another bacterium, it passes both the weapon and the drug resistance at the same time. This creates a dangerous situation where the use of common antibiotics in the community could inadvertently select for bacteria that are also better at surviving in the human body, making the resistance harder to eliminate.
The researchers then looked at 83 other bacterial samples from a previous survey of pregnant women in the same region to see if this pattern held true. They found that the nisin P weapon and the clindamycin resistance gene appeared together in 12 of the 83 samples. In every single one of those 12 cases, the bacteria also carried a gene for resistance to tetracycline, another common antibiotic. The statistical link was so strong that it is virtually impossible for this to be a coincidence. However, the researchers also found that in the other 71 samples, these genes were missing entirely. This suggests that the bacteria carrying this specific combination are a distinct group that has acquired a powerful, self-contained survival package.
Perhaps most importantly, the study revealed a clear divide in the bacterial population. The researchers found that a major lineage of the bacteria, known as ST1, which is common in other parts of the world, completely lacks both the nisin P weapon and the resistance genes. This means that in this specific population, the most common strains of the bacteria remain vulnerable to clindamycin. The study also identified that another common lineage, ST1010, carries a different kind of resistance that blocks the effectiveness of gentamicin, a drug often used in combination with penicillin for severe infections. These findings show that the bacterial population is not a uniform mass; it is a collection of different families, some of which have acquired dangerous new tools while others have not.
The discovery of this tight genetic link changes how scientists understand the spread of resistance. It suggests that the bacteria are not just randomly picking up resistance genes; they are acquiring complex packages that offer multiple advantages at once. The ability to produce a natural antibiotic helps the bacteria compete for space in the body, while the resistance genes protect them from medical treatment. Because these traits are physically connected on the same piece of DNA, they travel together. This means that reducing the use of one antibiotic might not be enough to stop the spread of the resistance, because the bacteria are also being selected for their ability to produce the natural weapon. The researchers propose that future studies should test whether the bacteria that produce this weapon can actually kill off the strains that do not, confirming that this genetic link provides a real survival advantage.
This work highlights the importance of looking at the full genetic picture. Previous studies, which relied on broken-up pieces of DNA, could only guess at the relationship between these genes. By assembling the complete genome, the researchers proved that the connection is real and physical. They also noted that while the genetic evidence is strong, the actual behavior of the bacteria—whether they truly produce the weapon in the body and whether they are truly resistant to the drugs—needs to be confirmed in a laboratory. The study serves as a warning that the bacteria are evolving in complex ways, and that understanding the full structure of their genetic code is essential for choosing the right treatments to protect newborns.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.